Sunday, October 17, 2021

Johns Hopkins Doc Says Natural Immunity 27 Times More Effective Than Vaccine

“Nurses, who are heroes, are now getting laid off. Soldiers are getting dishonorably discharged. They’ve got immunity. It’s just not the type that our public health officials have sanctioned.”

The Biden administration’s refusal to acknowledge the relevance of natural immunity in the fight against COVID-19 has become glaring.

The administration that constantly insists they are following the science is actually engaging in willful blindness.

Hell-bent on enforcing their COVID vaccine mandate, they deliberately ignore every scientific study that finds natural immunity to be superior to vaccine immunity.

Johns Hopkins University School of Medicine professor Dr. Marty Makary appeared as a guest on Thursday’s edition of “Morning Wire,” a podcast hosted by The Daily Wire.

“The data on natural immunity are now overwhelming,” Makary told the Morning Wire. “It turns out the hypothesis that our public health leaders had that vaccinated immunity is better and stronger than natural immunity was wrong. They got it backwards. And now we’ve got data from Israel showing that natural immunity is 27 times more effective than vaccinated immunity. And that supports 15 other studies.”

Despised by the left for his criticism of the vaccine mandate, Makary finds it bizarre that natural immunity is not seen as legitimate in the eyes of the U.S. government.

“It’s ruining the lives of people who are getting fired,” he said. “Nurses, who are heroes, are now getting laid off. Soldiers are getting dishonorably discharged. They’ve got immunity. It’s just not the type that our public health officials have sanctioned.”

“This is a failure of government, not a failure of science,” he declared. “But how about some flexibility? How about recognizing natural immunity and allowing those who have circulating antibodies to get credit? That’s how they do it in parts of Europe, and that’s how they do it in Israel.”

Makary said the recent drop-off in COVID cases can be attributed to both the tens of millions of Americans who have already had the virus and those who have been vaccinated.

The government refuses to acknowledge that the natural immunity acquired from having had COVID has played any role at all in moving us closer and faster to the desired goal of herd immunity. Makary is essentially saying natural immunity has played an enormous role.

This point is compelling and has been underreported.

“That decline [in new cases of COVID] is really natural immunity kicking in,” Makary explained. “What we’re seeing is that when a very few people in a population are susceptible, that is almost everybody has either had COVID or the vaccine. You do see this rapid decline. It’s basically a part of herd immunity kicking in.”

He believes “we’re done with the surges. What we may see is bumping cases, seasonally, depending on pockets of the country where there’s low immunity rates. And remember: breakthrough infections are real. They will happen, but they have downgraded COVID from a major public health threat to a mild, common, cold-like illness.”

Makary feels that the vaccines are safe and that complications are “exceedingly rare.” I know a few people who might disagree with that assessment.

At any rate, Makary told the Morning Wire, “When I talked to doctors nationwide, it’s pretty clear that the vaccine-related complications are exceedingly rare and the vaccines we have are safer than any other vaccine we’ve ever had in the past. And I think if you if you’re on the fence about getting vaccinated, you want to do it right now, like today, because we are getting to a point where it’s so contagious, it’s ripping through the population pretty quickly.”

The consequences of the government’s rejection of natural immunity as a valid reason to skip the vaccine have become apparent throughout the country, particularly in the health care industry and at all levels of law enforcement.

Democrats pushing Biden’s misguided blanket vaccine mandate all parrot the same old tired line: “We follow the science.” That’s nonsense. It has nothing to do with science and everything to do with politics — the politics of power and control.

In a September Op-Ed published in The Washington Post, Makary wrote, “It’s okay to have an incorrect scientific hypothesis. But when new data proves it wrong, you have to adapt. Unfortunately, many elected leaders and public health officials have held on far too long to the hypothesis that natural immunity offers unreliable protection against COVID-19 — a contention that is being rapidly debunked by science.”

Makary argued that over 15 studies have confirmed the power of natural immunity. He cited the recent 700,000-person Israeli study which found that those who had recovered from COVID “were 27 times less likely to get a second symptomatic COVID infection than those who were vaccinated.”

The results of the Israeli study, Makary wrote, confirmed the findings of a Cleveland Clinic study released in June. None of the health care workers who had previously contracted the virus were reinfected. The research team concluded that “individuals who have had SARS-CoV-2 infection are unlikely to benefit from COVID-19 vaccination.”

And the Cleveland Clinic’s results, he noted, affirmed the conclusions of a Washington University study conducted in May, which “found that even a mild COVID infection resulted in long-lasting immunity.”

Maybe it’s time for the Biden administration to take politics out of it and actually look at the science.


Immune response from Pfizer and Moderna COVID-19 vaccines spikes and then drops while antibody levels after J&J's shot remain low but stable, study finds

The immune response from the Pfizer-BioNTech and Moderna COVID-19 vaccines spikes and then drops drastically while the response from the Johnson & Johnson shot remains low but stable, a new study finds.

Researchers compared blood samples from a few dozen people fully vaccinated with one of three shots available in the U.S.

Findings - published in The New England Journal of Medicine and presented at the advisory committee of the U.S. Food and Drug Administration (FDA) on J&J boosters on Friday - showed antibody levels among people who got the Pfizer and Moderna were initially 12 times to 40 times higher than the J&J shot.

However, eight months later, the levels of the two-dose vaccines waned while those of the J&J vaccine 'remained relatively stable.'

The findings may throw a wrench in the advisory committee's discussions with some experts saying the results appear to suggest that a booster shot isn't needed after all.

For the study, researchers looked at 61 people at Beth Israel Deaconess Medical Center in Boston who were fully vaccinated.

Of the participants, 31 patients received the Pfizer vaccine, 22 received the Moderna vaccine and eight received the J&J vaccine.

Blood samples were taken between two to four weeks after the second dose of the Pfizer and Moderna vaccines or after the one J&J dose, six months later and then eight months later.

Neutralizing antibody levels were measured in ID50, or the number of antibodies produced to prevent infection in 50 percent of normal adult humans exposed

Results showed that the median level for Pfizer was 1,789 ID50 and for Moderna was 5,848 ID50.

However, by eight months, the levels substantially declined to 53 ID50 in Pfizer, or a 34-fold drop, and to 133 ID50 in Moderna, or a 44-fold drop.

Comparatively, two to four weeks after the one-dose vaccine, median antibody levels for J&J were 146 ID50, lower than the other two vaccines.

This number then jumped to 629 ID50 eight months later.

'I think the data should be reassuring for people who received the J&J vaccine, that immune responses are stable over time,' study co-author Dr Dan Barouch, director of the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center, told The Boston Globe.

'After about eight months, the antibody responses are relatively similar among the three vaccines.'

This difference may be attributed to the fact that the Pfizer and Moderna vaccines use new messenger RNA (mRNA) technology.

The technology works by using part of Covid's genetic code to trick the body into producing a harmless piece of the virus.

This gets the body to recognize the invader and mount an immune response by making customized proteins that are ready to attack if a person becomes infected.

But J&J's immunization is what is known as a viral vector vaccine, which combined genetic material from the new virus with the genes of the adenovirus -which causes the common cold - to induce an immune response.

The study also looked at levels of T-cells, which are a type of white blood cell that binds to and kills viruses, and found they were stable over eight months for all three vaccines.

Despite the findings that antibody levels for J&J's vaccine are steady, Barouch told The Globe that the firm still wants the FDA to authorize a booster dose.

'Although protection is maintained over time with a one-dose vaccine, it is not in the 90 percent range. It is in the 70 to 80 percent range,' he said during the meeting.

'A booster could bump efficacy to a level that is substantially higher.'




No comments: